Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
870 CHF | -0.80% | -0.80% | +1.22% |
02.04. | Aktien Schweiz deutlich im Minus - Gewinnmitnahmen belasten | DJ |
02.04. | Lonza holt den neuen CEO bei Siegfried | AW |
Kurzporträt
Mitarbeiterzahl: 3 945
Umsatz nach Geschäftsbereich
CHF in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Drug Substances
67,6
%
| 754 | 61,3 % | 860 | 67,6 % | +14.10% |
Drug Products
32,4
%
| 476 | 38,7 % | 412 | 32,4 % | -13.51% |
Umsatz je Region
CHF in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Switzerland
100,0
%
| 1 230 | 100,0 % | 1 271 | 100,0 % | +3.41% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Wolfgang Wienand
CEO | Chief Executive Officer | 52 | 01.08.10 |
Reto Suter
DFI | Director of Finance/CFO | 53 | 01.05.17 |
Jürgen Roos
CTO | Chief Tech/Sci/R&D Officer | 56 | 01.04.19 |
Christa Brügger
PRN | Corporate Officer/Principal | - | 01.02.14 |
Corporate Officer/Principal | 57 | 01.01.21 | |
Irene Wosgien
HRO | Human Resources Officer | 51 | 01.01.21 |
Marianne Späne
PRN | Corporate Officer/Principal | 61 | 01.06.04 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Martin Schmid
BRD | Director/Board Member | 55 | 01.01.16 |
Wolfram Carius
BRD | Director/Board Member | 63 | 01.01.14 |
Andreas Casutt
CHM | Chairman | 61 | 01.01.10 |
Beat Walti
BRD | Director/Board Member | 55 | 13.04.22 |
Isabelle Welton
BRD | Director/Board Member | 61 | 01.01.20 |
Alexandra Brand
BRD | Director/Board Member | 53 | 13.04.22 |
Director/Board Member | 50 | 20.04.23 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 4 513 000 | 3 957 148 ( 87,68 %) | 223 653 ( 4,956 %) | 87,68 % |
Unternehmensbesitz
Name | Aktien | % | Bewertung |
---|---|---|---|
SIEGFRIED HOLDING AG 5,01% | 223 811 | 5,01% | 228 855 259 $ |
Unternehmenskontakt
Konzerngesellschaften
Name | Kategorie und Branche |
---|---|
Siegfried AG
Siegfried AG Chemicals: AgriculturalProcess Industries Founded in 1873, Siegfried AG is a chemical product manufacturing company. The private company is based in Zofingen, Switzerland and is a part of Siegfried Holding AG. |
Chemicals: Agricultural
|
Siegfried (USA), Inc.
Siegfried (USA), Inc. Pharmaceuticals: MajorHealth Technology Part of Siegfried Holding AG, Siegfried (USA), Inc. is a private company that manufactures and supplies pharmaceutical products. The company is based in Pennsville, NJ. |
Pharmaceuticals: Major
|
Siegfried Hameln GmbH
Siegfried Hameln GmbH Pharmaceuticals: MajorHealth Technology Siegfried Hameln GmbH engages in the contract development, manufacturing, and packaging of solutions and suspensions in ampoules and vials. Its product portfolio includes injectables, opthalmics, and combination devices. The company was founded by Günther Kerstein in 1950 and is headquartered in Hameln, Germany. |
Pharmaceuticals: Major
|
BASF PharmaChemikalien GmbH & COKG
BASF PharmaChemikalien GmbH & COKG Chemicals: Major DiversifiedProcess Industries Part of Siegfried Holding AG, BASF PharmaChemikalien GmbH & COKG is a German company that offers innovative products to meet the current and future needs of businesses and society. The private company is based in Ludwigshafen, Germany. The company's product range can be found through industry research or their product search. The company's goal is to grow profitably and create value for society by creating chemistry for a sustainable future. |
Chemicals: Major Diversified
|
Siegfried Finance AG
| |
BASF Pharma (St. Vulbas) SAS
BASF Pharma (St. Vulbas) SAS Chemicals: SpecialtyProcess Industries BASF Pharma (St. Vulbas) SAS manufactures basic organic chemicals. The company is headquartered in Saint-Vulbas, France. |
Chemicals: Specialty
|
Siegfried St. Vulbas SASU
Siegfried St. Vulbas SASU Pharmaceuticals: MajorHealth Technology Part of Siegfried Holding AG, Siegfried St. Vulbas SASU is a pharmaceutical and French chemical company that offers integrated partnership benefits to its customers. The private company is based in Saint-Vulbas, France. The company combines a long tradition of pharmaceutical and chemistry with the innovative approach of an "integrated supplier" to provide more synergy, expertise, and value. The company was founded in 1992. Philippe Moy has been the CEO of the company since 2020. |
Pharmaceuticals: Major
|
Siegfried PharmaChemikalien Minden GmbH
Siegfried PharmaChemikalien Minden GmbH Chemicals: SpecialtyProcess Industries Part of Siegfried Holding AG, Siegfried PharmaChemikalien Minden GmbH produces pharmaceutical ingredients. The private company is based in Minden, Germany. The CEOs of the German company are Marco Millies, René Imwinkelried. |
Chemicals: Specialty
|
Siegfried Evionnaz SA
|
Sektor
Umsatz nach Geschäftsbereich
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+1.22% | 4.09 Mrd. | |
+24.17% | 556 Mrd. | |
-6.33% | 354 Mrd. | |
+19.90% | 331 Mrd. | |
+7.95% | 296 Mrd. | |
+13.45% | 233 Mrd. | |
+6.04% | 201 Mrd. | |
-10.51% | 193 Mrd. | |
-12.26% | 143 Mrd. | |
-6.47% | 144 Mrd. |
- Börse
- Aktien
- 891169 Aktie
- Unternehmen Siegfried Holding AG